MeSH term
Frequency | Condition_Probility | Cell Survival | 3 | 0.0 |
Child | 6 | 0.0 |
Humans | 61 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
3T3 Cells | 3 | 0.0 |
Animals | 24 | 0.0 |
Cell Division | 3 | 0.0 |
Mice | 17 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Rats | 2 | 0.0 |
Transfection | 6 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 6 | 0.0 |
Adult | 10 | 0.0 |
Chromosomes, Human, Pair 15/*genetics | 3 | 3.0 |
Female | 29 | 0.0 |
In Situ Hybridization, Fluorescence | 9 | 0.0 |
Karyotyping | 3 | 0.0 |
Pregnancy | 4 | 0.0 |
*Ring Chromosomes | 3 | 9.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Kinetics | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
Mutation | 4 | 0.0 |
Protein Binding | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Child, Preschool | 6 | 0.0 |
*Chromosome Deletion | 4 | 0.0 |
Comparative Study | 5 | 0.0 |
Cytogenetic Analysis | 2 | 1.0 |
Gene Amplification/*genetics | 3 | 2.0 |
Infant | 4 | 0.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Chromosome Banding | 3 | 0.0 |
Phenotype | 5 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
*Trisomy | 2 | 1.0 |
DNA, Complementary | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Receptor, IGF Type 1/*genetics | 9 | 37.0 |
Swine/*genetics | 3 | 2.0 |
Apoptosis | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Neoplasm Transplantation | 2 | 0.0 |
Oligodeoxyribonucleotides, Antisense/pharmacology | 2 | 4.0 |
Phosphorylation | 2 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
*Chromosomes, Human, Pair 15 | 10 | 4.0 |
*Gene Amplification | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
Insulin-Like Growth Factor II/*metabolism | 2 | 7.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Receptors, Somatomedin/genetics | 2 | 40.0 |
Genetic Markers | 2 | 0.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis/methods | 2 | 2.0 |
Blotting, Southern | 3 | 0.0 |
Transplantation, Heterologous | 3 | 0.0 |
Disease Progression | 2 | 0.0 |
Insulin-Like Growth Factor I/*biosynthesis/genetics | 3 | 50.0 |
Insulin-Like Growth Factor II/*biosynthesis/genetics | 3 | 21.0 |
Mice, Transgenic | 2 | 0.0 |
Neoplasm Metastasis | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Abortion, Induced | 2 | 6.0 |
Receptor, IGF Type 1/physiology | 2 | 28.0 |
Signal Transduction | 3 | 0.0 |
Cell Line | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Syndrome | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Receptor, IGF Type 1/*biosynthesis/genetics | 2 | 50.0 |
Receptor, IGF Type 2/*biosynthesis/genetics | 2 | 100.0 |
Transcription, Genetic | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
Genotype | 3 | 0.0 |
Pedigree | 7 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Crosses, Genetic | 3 | 0.0 |
Base Sequence | 6 | 0.0 |
Chickens/*genetics | 2 | 2.0 |
In Situ Hybridization | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Mice, Nude | 3 | 0.0 |
Abnormalities, Multiple/*genetics | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Abnormalities, Multiple/genetics | 2 | 2.0 |
Insulin-Like Growth Factor I/*metabolism | 2 | 1.0 |
*Antineoplastic Agents | 2 | 9.0 |
Gene Expression Regulation/drug effects/*genetics | 2 | 14.0 |
Neoplasms/*drug therapy | 2 | 1.0 |
RNA, Small Interfering | 2 | 3.0 |
Receptor, IGF Type 1/*antagonists & inhibitors/genetics | 2 | 100.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Receptors, Somatomedin | 3 | 6.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Receptors, Cell Surface/*genetics | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Insulin-Like Growth Factor I/metabolism | 2 | 1.0 |
